Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Discovery Laboratories: The Surfaxin Launch And Beyond
Seeking Alpha
Friday, March 22, 2013 - 11:37am
tags:
Surfaxin, Discovery Labs
Medical device maker Cytori loses approval fight
Reuters
Friday, March 22, 2013 - 11:30am
tags:
Cytori, stem cells, devices
EMA rejects Genzyme re-examination request for Kynamro
Yahoo/Fly on the Wall
Friday, March 22, 2013 - 11:29am
tags:
Europe, Genzyme, Kynamro, Sanofi, hypercholesterolemia
Bayer opposes efforts to consolidate IUD lawsuits
Reuters
Friday, March 22, 2013 - 10:57am
tags:
IUD, lawsuits, Bayer
Takeda launches Takeda Ecuador
Pharma Times, UK
Friday, March 22, 2013 - 10:56am
tags:
Takeda, Ecuador
Sanofi’s Lemtrada MS Drug Effective in Extension Trial
Bloomberg
Friday, March 22, 2013 - 10:55am
tags:
Sanofi, Lemtrada, MS, multiple sclerosis
J&J's answer to Botox may escalate war on wrinkles
Reuters
Friday, March 22, 2013 - 10:53am
tags:
JNJ, Botox, Allergan, Mentor, Dysport, Xeomin
Biotechs Get First State Victory Over Biosimilars
Pharmalot
Friday, March 22, 2013 - 10:50am
tags:
biotech, biosimilars, Virginia
Drug Manufacturing Stocks Tumble on FDA Concerns
Yahoo/Accesswire
Friday, March 22, 2013 - 10:49am
tags:
drug manufacturing, Depomed, Novo Nordisk
Trius Therapeutics Is A Strong Investment Short And Long Term
Seeking Alpha
Friday, March 22, 2013 - 10:47am
tags:
Trius Therapeutics, tedizolid
Bayer, J&J’s Xarelto Wins EU Backing for Expanded Use
Bloomberg
Friday, March 22, 2013 - 10:46am
tags:
Bayer, JNJ, Europe, Xarelto, bloodthinners
Bristol-Myers earnings could double by end of decade, says Goldman
Yahoo/Fly on the Wall
Friday, March 22, 2013 - 10:44am
tags:
Bristol-Myers Squibb
US Supreme Court Will Hear 'Pay for Delay' Drug Case
CNBC
Friday, March 22, 2013 - 10:44am
tags:
pay-for-delay, Supreme Court
Dynavax Surprises: Announces Strategic Global Operations Hire
Seeking Alpha
Friday, March 22, 2013 - 10:43am
tags:
Novartis, Dynavax
Flamel: Near-Term, Under The Radar FDA Catalyst Trade
Seeking Alpha
Friday, March 22, 2013 - 10:42am
tags:
FDA, GSK, Flamel, Coreg CR
Drug maker JNJ: $327M deceptive marketing penalty should be invalidated because no one in SC hurt
Yahoo/AP
Friday, March 22, 2013 - 10:40am
tags:
JNJ, Janssen, South Carolina
Merck: A Bright Future Ahead
Seeking Alpha
Friday, March 22, 2013 - 10:39am
tags:
Merck
How AstraZeneca Will Use A Diagnostic To Market Its Blood Thinner
Forbes
Friday, March 22, 2013 - 10:38am
tags:
bloodthinners, AstraZeneca, Brilinta
GSK malaria vaccine's effectiveness dwindles rapidly in study
Fierce Biotech
Thursday, March 21, 2013 - 12:58pm
tags:
GSK, vaccines, malaria
Santarus' Uceris Data Published
Yahoo/Zacks
Thursday, March 21, 2013 - 12:55pm
tags:
Santarus, Uceris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.